ALSENLITE: Senolytics for Alzheimer's Disease

Clinical trial NCT04785300 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04785300
Sponsor: Mayo Clinic
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Mild Cognitive Impairment Alzheimer Disease

Start date: 2022-07-06
Primary completion: 2026-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.